ConductScience.org, home

Paper33482121

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.

Gay CM and 29 others. Cancer Cell, 2021. Cited by 863 papers, by iCite.

Cite this record

ConductScience Library. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Papers, record 33482121. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33482121

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.
PubMed
Journal
Cancer Cell
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
863
iCite
Relative citation ratio, by iCite
43.3
iCite
Revised in PubMed
2024-04-02
PubMed

Authors30

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gay CMCarl M
2Stewart CAC Allison
3Park EMElizabeth M
4Diao LLixia
5Groves SMSarah M
6Heeke SSimon
7Nabet BYBarzin Y
8Fujimoto JJunya
9Solis LMLuisa M
10Lu WWei
11Xi YYuanxin
12Cardnell RJRobert J
13Wang QQi
14Fabbri GGiulia
15Cargill KRKasey R
16Vokes NINatalie I
17Ramkumar KKavya
18Zhang BBingnan
19Della Corte CMCarminia M
20Robson PPaul

Source PubMed

See all 30 authorsDownload CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ImmunityMajor topic
Lung NeoplasmsMajor topic
Small Cell Lung CarcinomaMajor topic
Transcription FactorsMajor topic
Animals
Cell Line, Tumor
Cisplatin
Female
Gene Expression Regulation, Neoplastic
Humans
Mice, Nude
Prognosis
Mice

Source PubMed

Download CSV of topics

Grants10

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA016672NCI NIH HHSUnited StatesP30CA016672PubMed and NIHNIH RePORTER
U24 CA213274NCI NIH HHSUnited StatesU24CA213274PubMed and NIHNIH RePORTER
R50 CA243698NCI NIH HHSUnited StatesR50CA243698PubMed and NIHNIH RePORTER
R01 CA207295NCI NIH HHSUnited StatesR01CA207295PubMed and NIHNIH RePORTER
P50 CA070907NCI NIH HHSUnited StatesP50CA070907PubMed and NIHNIH RePORTER
T32 CA009666NCI NIH HHSUnited StatesT32CA009666PubMed and NIHNIH RePORTER
U01 CA215845NCI NIH HHSUnited StatesU01CA215845PubMedNIH RePORTER
U01 CA213273NCI NIH HHSUnited StatesU01CA213273PubMed and NIHNIH RePORTER
P30 CA034196NCI NIH HHSUnited StatesP30CA034196PubMed and NIHNIH RePORTER
U01 CA213338NCI NIH HHSUnited StatesU01CA213338PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05257551Tempus Small Cell Lung Cancer Observational Study (Sculptor)Background

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in33577787Small cell lung cancer enters the era of precision medicine.https://conductscience.org/library/papers/33577787

Source PubMed

Download CSV of comments and corrections

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131061481Determining cell type abundance and expression from bulk tissues with digital cytometry.Nat Biotechnol2019https://conductscience.org/library/papers/31061481PubMed
229118061Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression.Clin Cancer Res2018https://conductscience.org/library/papers/29118061PubMed
328844817Labetuzumab govitecan in metastatic colorectal cancer.Lancet Oncol2017https://conductscience.org/library/papers/28844817PubMed
430926931Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.Nat Rev Cancer2019https://conductscience.org/library/papers/30926931PubMed
531870883Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies.J Thorac Oncol2020https://conductscience.org/library/papers/31870883PubMed
631416802Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer.Cancer Discov2019https://conductscience.org/library/papers/31416802PubMed
728212573Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.Oncotarget2017https://conductscience.org/library/papers/28212573PubMed
826168399Comprehensive genomic profiles of small cell lung cancer.Nature2015https://conductscience.org/library/papers/26168399PubMed
930280641First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.N Engl J Med2018https://conductscience.org/library/papers/30280641PubMed
1029088717Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies.Oncotarget2017https://conductscience.org/library/papers/29088717PubMed
1127269741Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial.Lancet Oncol2016https://conductscience.org/library/papers/27269741PubMed
1222961666Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.Cancer Discov2012https://conductscience.org/library/papers/22961666PubMed
1330089906RNA velocity of single cells.Nature2018https://conductscience.org/library/papers/30089906PubMed
1428650338IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.J Clin Invest2017https://conductscience.org/library/papers/28650338PubMed
1530038220Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses.Nat Med2018https://conductscience.org/library/papers/30038220PubMed
1630557521T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028.J Clin Oncol2019https://conductscience.org/library/papers/30557521PubMed
1730257981Differential Sensitivity Analysis for Resistant Malignancies (DISARM) Identifies Common Candidate Therapies across Platinum-Resistant Cancers.Clin Cancer Res2019https://conductscience.org/library/papers/30257981PubMed
1827452466ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs.Cell Rep2016https://conductscience.org/library/papers/27452466PubMed
1928089889MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.Cancer Cell2017https://conductscience.org/library/papers/28089889PubMed
2030231367Immune Checkpoint Inhibitors in the Management of Lung Cancer.Am Soc Clin Oncol Educ Book2018https://conductscience.org/library/papers/30231367PubMed

See all 62 referencesDownload CSV of references

Cited by635

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 863 citations.

PMIDTitleJournalYearIn PapersSource
42989294MAP of molecular analyses in real-worlD oncology centers - MAPpaMoNDO: a study of the translational research Young GOIM group.J Transl Med2026https://conductscience.org/library/papers/42989294PubMed
42983745SCG3 and YAP1 define molecular subtypes of small cell carcinoma of the cervix with divergent multi-omics features and prognostic outcomes.J Transl Med2026https://conductscience.org/library/papers/42983745PubMed
42974076Development and Validation of a Gene Expression-Based Prognostic Model for Patients With Small Cell Lung Cancer Treated With Chemotherapy.MedComm (2020)2026https://conductscience.org/library/papers/42974076PubMed
42967940Molecular and immune heterogeneity across limited-stage and extensive-stage small cell lung cancer.Exp Mol Med2026https://conductscience.org/library/papers/42967940PubMed
42914976Cell-state-specific metabolic networks govern ferroptosis versus apoptosis in small cell lung cancer.Cell2026https://conductscience.org/library/papers/42914976PubMed
42907953Clinical and pathological characteristics, immune microenvironment, and survival analysis of molecular subtypes of surgically resected small cell lung cancer.BMC Cancer2026https://conductscience.org/library/papers/42907953PubMed
42905834CREBBP loss drives immune evasion by epigenetically silencing STING and MHC-I in small cell lung cancer.Sci Adv2026https://conductscience.org/library/papers/42905834PubMed
42903730Spatial and maturational characterisation of tertiary lymphoid structures predicts immunotherapy response in extensive-stage small cell lung cancer.Clin Transl Immunology2026https://conductscience.org/library/papers/42903730PubMed
42900351Vibostolimab Coformulated with Pembrolizumab Plus Chemotherapy as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer.Target Oncol2026https://conductscience.org/library/papers/42900351PubMed
42894882NK cell immune fitness stratifies small cell lung cancer into four functional states associated with clinical response.J Liq Biopsy2026https://conductscience.org/library/papers/42894882PubMed
42882853AI-Driven Multi-Omics Approaches for Deciphering Small-Cell Lung Cancer Heterogeneity Using Nucleic-Acid-Based Features.Cancers (Basel)2026https://conductscience.org/library/papers/42882853PubMed
42876375Clinicopathological Features of DLL3 Expression and T-Cell Infiltration in LCNEC: Insights From Pathology and Clinical Response to Tarlatamab.Thorac Cancer2026https://conductscience.org/library/papers/42876375PubMed
42875653Reframing cancer therapy through tumor plasticity.Nat Cancer2026https://conductscience.org/library/papers/42875653PubMed
42866165Artificial intelligence and radiomics in small cell lung cancer: a narrative review of imaging and multisource data integration.J Thorac Dis2026https://conductscience.org/library/papers/42866165PubMed
42840183The Five-Decade Journey of Small Cell Lung Cancer.Cancer Commun (Lond)2026https://conductscience.org/library/papers/42840183PubMed
42820295Plasma nucleosome profiling reports on tumor burden and molecular subtypes in small cell lung cancer.J Clin Invest2026https://conductscience.org/library/papers/42820295PubMed
42814835Sensitizing tumor response to topoisomerase I antibody-drug conjugate by selective CDK7 inhibition.Sci Adv2026https://conductscience.org/library/papers/42814835PubMed
42778205Thymic neuroendocrine tumours: molecular landscape, immune microenvironment and therapeutic perspectives.Eur Respir Rev2026https://conductscience.org/library/papers/42778205PubMed
42768009XPO1-mediated TRIM21 nuclear export reprograms TREM2+ macrophage polarization by targeting IRF3 to augment anti-PD-1 efficacy in small cell lung cancer.Nat Commun2026https://conductscience.org/library/papers/42768009PubMed
42761714Lineage plasticity and immune invisibility in primary SCLC and LUAD-to-SCLC transformation: antigen presentation loss and therapeutic redirection.Front Immunol2026https://conductscience.org/library/papers/42761714PubMed

See all 635 cited byDownload CSV of cited by

Genes53

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ASCL1429PubTator's text mininghttps://conductscience.org/library/genes/429NCBI Gene
AXL558PubTator's text mininghttps://conductscience.org/library/genes/558NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BTK695PubTator's text mininghttps://conductscience.org/library/genes/695NCBI Gene
CCL56352PubTator's text mininghttps://conductscience.org/library/genes/6352NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD36948PubTator's text mininghttps://conductscience.org/library/genes/948NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CD80941PubTator's text mininghttps://conductscience.org/library/genes/941NCBI Gene
CD86942PubTator's text mininghttps://conductscience.org/library/genes/942NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CD8B926PubTator's text mininghttps://conductscience.org/library/genes/926NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
CEACAM51048PubTator's text mininghttps://conductscience.org/library/genes/1048NCBI Gene
CHGA1113PubTator's text mininghttps://conductscience.org/library/genes/1113NCBI Gene
COL11A21302PubTator's text mininghttps://conductscience.org/library/genes/1302NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CXCL103627PubTator's text mininghttps://conductscience.org/library/genes/3627NCBI Gene
DLL310683PubTator's text mininghttps://conductscience.org/library/genes/10683NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene

See all 53 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33482121

GET https://conductscience.org/api/papers/v1/33482121/authors?page=2